Warm Autoimmune Hemolytic Anemia (WAIHA) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

<p>The 7 major warm autoimmune hemolytic anemia (WAIHA) markets reached a value of US$ 730.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,486.9 Million by 2034, exhibiting a growth rate (CAGR) of 15.26% during 2024-2034.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>Report Attribute</strong></div>
</th>
<th scope="col">
<div style="text-align:left">Key Statistics</div>
</th>
</tr>
<tr>
<td><strong>Base Year</strong></td>
<td>2023</td>
</tr>
<tr>
<td><strong>Forecast Years</strong></td>
<td>2024-2034</td>
</tr>
<tr>
<td><strong>Historical Years</strong></td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td>
<div><strong>Market Size in 2023</strong></div>
</td>
<td>
<div>US$ 730.8 Million</div>
</td>
</tr>
<tr>
<td>
<div><strong>Market Forecast in 2034</strong></div>
</td>
<td>
<div>US$ 3,486.9&nbsp;Million</div>
</td>
</tr>
<tr>
<td>
<div><strong>Market Growth Rate (2024-2034)</strong></div>
</td>
<td>
<div>15.26%</div>
</td>
</tr>
</thead>
</table>